Compare · NVCN vs RVLP
NVCN vs RVLP
Side-by-side comparison of Neovasc Inc. (NVCN) and RVL Pharmaceuticals plc (RVLP): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both NVCN and RVLP operate in Pharmaceuticals and Biotechnology (Health Care), so they compete in similar markets.
- RVLP is the larger of the two at $90.0M, about 3.2x NVCN ($27.8M).
- RVLP has more recent analyst coverage (2 ratings vs 0 for NVCN).
- Company
- Neovasc Inc.
- RVL Pharmaceuticals plc
- Price
- $30.03+1.35%
- $0.03-29.51%
- Market cap
- $27.8M
- $90.0M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Pharmaceuticals and Biotechnology
- Pharmaceuticals and Biotechnology
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2018
- News (4w)
- 0
- 0
- Recent ratings
- 0
- 2
Neovasc Inc.
Neovasc Inc., a specialty medical device company, develops, manufactures, and markets medical devices for cardiovascular marketplace in Europe, Canada, the United States, and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.
RVL Pharmaceuticals plc
RVL Pharmaceuticals plc, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. The company is commercializing Upneeq (RVL-1201), an oxymetazoline hydrochloride ophthalmic solution, for the treatment of acquired blepharoptosis, or low-lying eyelid in adults. The company was formerly known as Osmotica Pharmaceuticals plc and changed its name to RVL Pharmaceuticals plc in January 2022. RVL Pharmaceuticals plc is headquartered in Bridgewater, New Jersey.
Latest NVCN
- Volato Announces Changes to Board Composition
- SEC Form EFFECT filed by Neovasc Inc.
- SEC Form 15F-12B filed by Neovasc Inc.
- SEC Form 6-K filed by Neovasc Inc.
- SEC Form 6-K filed by Neovasc Inc.
- SEC Form RW filed by Neovasc Inc.
- SEC Form F-10POS filed by Neovasc Inc.
- SEC Form POS AM filed by Neovasc Inc.
- SEC Form S-8 POS filed by Neovasc Inc.
- SEC Form 25-NSE filed by Neovasc Inc.
Latest RVLP
- RVL Pharmaceuticals plc filed SEC Form 8-K: Other Events
- RVL Pharmaceuticals plc filed SEC Form 8-K: Other Events
- RVL Pharmaceuticals plc filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- SEC Form SC 13D/A filed by RVL Pharmaceuticals plc (Amendment)
- RVL Pharmaceuticals plc filed SEC Form 8-K: Bankruptcy or Receivership, Completion of Acquisition or Disposition of Assets, Other Events, Financial Statements and Exhibits
- SEC Form 25-NSE filed by RVL Pharmaceuticals plc
- SEC Form DEF 14A filed by RVL Pharmaceuticals plc
- SEC Form PRE 14A filed by RVL Pharmaceuticals plc
- RVL Pharmaceuticals plc filed SEC Form 8-K: Regulation FD Disclosure
- SEC Form SC 13D/A filed by RVL Pharmaceuticals plc (Amendment)